-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Gene Editing for Severe Congenital Neutropenia – Current Advances and Critical Considerations

Program: Scientific Program
Session: JOINT SESSION: Therapeutic Gene Editing of Stem Cells in Classical and Malignant Hematology
Hematology Disease Topics & Pathways:
Research, Translational Research, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Drug development, Diseases, Treatment Considerations, Technology and Procedures, Gene editing
Sunday, December 8, 2024, 9:30 AM-11:05 AM

Julia Skokowa, MD, PhD

Department of Oncology, Hematology, Immunology, Rheumatology and Clinical Immunology, University Hospital Tübingen, Tübingen, Germany; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, University Hospital Tuebingen, Germany, Division of Translational Oncology, Tuebingen, Germany

Disclosures: No relevant conflicts of interest to declare.

See more of: JOINT SESSION: Therapeutic Gene Editing of Stem Cells in Classical and Malignant Hematology
See more of: Scientific Program
<< Previous Presentation | Next Presentation